Fujian Raynen Technology Balance Sheet Health
Financial Health criteria checks 5/6
Fujian Raynen Technology has a total shareholder equity of CN¥1.3B and total debt of CN¥371.3M, which brings its debt-to-equity ratio to 27.7%. Its total assets and total liabilities are CN¥2.3B and CN¥948.5M respectively. Fujian Raynen Technology's EBIT is CN¥74.5M making its interest coverage ratio 7.3. It has cash and short-term investments of CN¥178.3M.
Key information
27.7%
Debt to equity ratio
CN¥371.33m
Debt
Interest coverage ratio | 7.3x |
Cash | CN¥178.26m |
Equity | CN¥1.34b |
Total liabilities | CN¥948.51m |
Total assets | CN¥2.29b |
Recent financial health updates
No updates
Recent updates
Fujian Raynen Technology Co., Ltd. (SHSE:603933) Stock Rockets 30% As Investors Are Less Pessimistic Than Expected
Dec 02We Think That There Are Issues Underlying Fujian Raynen Technology's (SHSE:603933) Earnings
Nov 04Fujian Raynen Technology Co., Ltd.'s (SHSE:603933) Price Is Out Of Tune With Earnings
Sep 28Fujian Raynen Technology Co., Ltd. (SHSE:603933) Investors Are Less Pessimistic Than Expected
Jun 07Some Investors May Be Worried About Fujian Raynen Technology's (SHSE:603933) Returns On Capital
Apr 23Concerns Surrounding Fujian Raynen Technology's (SHSE:603933) Performance
Apr 02Earnings Tell The Story For Fujian Raynen Technology Co., Ltd. (SHSE:603933) As Its Stock Soars 27%
Feb 27Financial Position Analysis
Short Term Liabilities: 603933's short term assets (CN¥1.6B) exceed its short term liabilities (CN¥895.3M).
Long Term Liabilities: 603933's short term assets (CN¥1.6B) exceed its long term liabilities (CN¥53.2M).
Debt to Equity History and Analysis
Debt Level: 603933's net debt to equity ratio (14.4%) is considered satisfactory.
Reducing Debt: 603933's debt to equity ratio has increased from 15.4% to 27.7% over the past 5 years.
Debt Coverage: 603933's debt is well covered by operating cash flow (40.3%).
Interest Coverage: 603933's interest payments on its debt are well covered by EBIT (7.3x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/26 07:36 |
End of Day Share Price | 2024/12/26 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Fujian Raynen Technology Co., Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Yang Yang | Huatai Research |
Yuming Yuan | Industrial Securities Co. Ltd. |